Manipal > Institutions > Life Sciences > MLSC Manipal > Know MLSC > Leadership > Director


Select a Leadership 

Image
Dr. K Satyamoorthy
M.Sc., M.B.A., Ph.D.
Department of Biotechnology
ksatyamoorthy@manipal.edu


Background:

  • 1994-2001: Senior Scientist, The Wistar Institute, Philadelphia, PA
  • 2001- Senior Scientist and Professor, MAHE, Manipal, India.
  • 2002- Professor & Head, Department of Biotechnology, Manipal Life Sciences Centre, Manipal
  • 2006- Director, Manipal Life Sciences Centre, Manipal
Areas of Interest:

Molecular Biology, Human Genetics, Eukaryotic Transcription, Epigenetics

Research Publications:

Dr. K. Satyamoothy has over 80 publications in the form of scientific articles in international journals and book chapters.

  • Vahab SA, Sen S, Ravindran N, Mony S, Mathew A, Vuayan N, Nayak G, Bhaskaranand N, Banerjee M, Satyamoorthy K. Genetic association of ABCB1 (MDR1) single nucleotide polymorphisms and medically refractory epilepsy in Indian children. Drug Metabolism and Pharmacokinetics, 2009, 24, 255-260.
  • Bishen K.A, Radhakrishna R, Satyamoorthy K. The role of basic fibroblast growth factor in oral submucous fibrosis pathogenesis. J Oral Pathol Med 2008, 37:402-411.
  • Saadi Abdul Vahab, Satyajit Patra and Kapaettu Satyamoorthy. Pharmacogenomics in Clinical Research. Book chapter in “Biotechnology – Concepts and Applications”, eds Vittal RR and Bhat R, Publ., Narosa Publs., Mumbai. 1-26.
  • Radhakrishnan R, Solomon M, Satyamoorthy K, Martin LE, Lingen MW. Tissue microarray – a high-throughput molecular analysis in head and neck cancer. J Oral Pathol Med 2008; 37: 166 – 176.
  • Segal N., Andriani, F, Pfeiffer, L. Kamath, P, Lin, N, Satyamoorthy, K, Egles, C, Garlick, JA. The basement membrane microenvironment directs the normalization and survival of bioengineered human skin equivalents. Matrix Biology; 2008, 27, 163-170.
  • Meier F, Schittek B, Busch S, Garbe C, Smalley K, Satyamoorthy K, Li G, Herlyn M. The RAS/RAF/MEK/ERK and PI3K/AKT signalling pathways present molecular targets for the effective treatment of advanced melanoma. Front Biosci. 2005 Sep 1;10:2986-3001.
  • Satyamoorthy, K., Li, G., Garrero, M.R., Bros, M.S., Volpe, P., Weber, B.L., van Belle, P., Elder, D.E., and Herlyn, M. 2003. Constitutive mitogen activated protein kinase activation in melanoma is mediated by both BRAF mutations and autocrine growth factor stimulation. Cancer Res., 63: 756-759.